Claude Maraoui - Jan 3, 2024 Form 4 Insider Report for Journey Medical Corp (DERM)

Role
President & CEO, Director
Signature
/s/ Ramsey Alloush, attorney-in-fact
Stock symbol
DERM
Transactions as of
Jan 3, 2024
Transactions value $
$0
Form type
4
Date filed
4/16/2025, 07:07 PM
Previous filing
Sep 8, 2023
Next filing
Mar 25, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DERM Common Stock, $0.0001 par value Award $0 +175K +8.74% $0.00 2.18M Jan 3, 2024 Direct F1, F3
transaction DERM Common Stock, $0.0001 par value Award $0 +175K +8.03% $0.00 2.35M May 1, 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 3, 2024, the reporting person was granted 175,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that vested or will vest in accordance with the following schedule: 58,333 shares on July 3, 2024, 58,333 shares on July 3, 2025 and 58,334 shares on July 3, 2026.
F2 On May 1, 2024, the reporting person was granted 175,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 58,333 shares on May 1, 2025, 58,333 shares on May 1, 2026 and 58,334 shares on May 1, 2027.
F3 Includes restricted stock units, which vest over various time periods. Due to administrative error, the above transactions are being reported late. The aggregate amount of securities beneficially owned includes the delinquent transactions plus all transactions reported in Form 4s filed after the date of the delinquent transactions.